Previously, the induced autophagy by PARP-1 inhibitors was reported in other tumor cells (Arun et al., 2015; Liu et al., 2019; Santiago-O'Farrill et al., 2020; Zai et al., 2020), but not in HCT-116. This evidence concerns the gene PARP1 and neoplasm.